| 1446713-20-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• CAS: 1446713-20-7
• 化学式: C₂₇H₂₇ClN₈O₂
• 分子量: 531.017
• InChiKey: ZKLJKUCDLRFEQR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  38.0
• 可旋转键数：
  10.0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  126.63
• 氢给体数：
  1.0
• 氢受体数：
  10.0

反应信息

• 作为反应物：
  描述：

  在 盐酸羟胺 、 potassium hydroxide 作用下， 以 甲醇 为溶剂， 反应 3.0h， 以53%的产率得到7-[5-[3-[4-amino-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]triazol-1-yl]-N-hydroxyheptanamide
  参考文献：
  名称：

  Development of a Chimeric c-Src Kinase and HDAC Inhibitor

  摘要：

  On the basis of synergism observed between a selective c-Src kinase inhibitor with an HDAC inhibitor, the development of the first chimeric c-Src kinase and HDAC inhibitor is described. The optimized chimeric inhibitor is shown to be a potent c-Src and HDAC inhibitor. Chimeric inhibitor 4 is further shown to be highly efficacious in cancer cell lines and significantly more efficacious than a dual-targeting strategy using discrete c-Src and HDAC inhibitors.

  DOI：

  10.1021/ml400175d
• 作为产物：
  描述：

  methyl 7-azidoheptanoate 、 3-(4-Chlorophenyl)-1-(3-ethynylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 在 chloro(1,5-cyclooctadiene)(pentamethylcyclopentadiene)ruthenium(II) 作用下， 以 四氢呋喃 为溶剂， 以47%的产率得到
  参考文献：
  名称：

  Development of a Chimeric c-Src Kinase and HDAC Inhibitor

  摘要：

  On the basis of synergism observed between a selective c-Src kinase inhibitor with an HDAC inhibitor, the development of the first chimeric c-Src kinase and HDAC inhibitor is described. The optimized chimeric inhibitor is shown to be a potent c-Src and HDAC inhibitor. Chimeric inhibitor 4 is further shown to be highly efficacious in cancer cell lines and significantly more efficacious than a dual-targeting strategy using discrete c-Src and HDAC inhibitors.

  DOI：

  10.1021/ml400175d